Activated Hepatic Nuclear Factor-κB in Experimental Colitis Regulates CYP2A5 and Metronidazole Disposition

4.5 (684) ·

$ 1.00 ·

In stock

Description

Regulation of Drug-Metabolizing Enzymes and Drug Metabolism by

An NF-κB–driven lncRNA orchestrates colitis and circadian clock

Inflammatory bowel disease Nutritional Immunology and Molecular

Transcriptional Silencing of the Death Gene BNIP3 by Cooperative

Bioengineered Magnetoferritin Nanoprobes for Single-Dose Nuclear

Molecular docking prediction and in vitro studies elucidate anti

Activated Hepatic Nuclear Factor-κB in Experimental Colitis

Transcriptional Silencing of the Death Gene BNIP3 by Cooperative

Nitroimidazoles: Molecular Fireworks That Combat a Broad Spectrum

Geniposide ameliorates TNBS-induced experimental colitis in rats

Activated Hepatic Nuclear Factor-κB in Experimental Colitis

1-(2-Hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole

Molecular Pharmaceutics

Malaria-induced Alterations of Drug Kinetics and Metabolism in